Senior regulatory and quality leadership — built inside the industries we now advise.

Consultant to blue-chip pharma. Former global quality lead at a FTSE 100 consumer business.

Senior regulatory and quality leader whose career spans consulting for blue-chip pharmaceutical multinationals and leading global quality operations for a FTSE 100 consumer goods business. Formally trained as a Responsible Person under UK GDP (Cogent Gold Standard accredited course) and now building practical, MHRA-aligned RP frameworks for UK operators. Hands-on background across GMP/GDP-regulated quality systems, supplier qualification, technical due diligence and operational delivery — applied to medicinal cannabis supply chains, controlled drug compliance and CBD novel foods.

Trusted by founders, boards and investors to bring structure, reduce delivery risk and move complex programmes forward — including market entry, international supply chain build, scale-up, turnaround and restructuring. Works selectively with compliance-focused founders building businesses designed to withstand regulatory scrutiny from day one. Strong at bridging regulators, technical teams, manufacturers and commercial stakeholders to convert strategy into executable, compliant plans.